跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,211 条关于
“CITY-FXI”
全部
2,211
临床试验
1,050
药物
196
机构
152
资讯
813
前天
Clinical-Stage RNAi Developer City Therapeutics Files for Nasdaq IPO
5个月前
Waters Receives FDA 510(k) Clearance for BD BACTEC FXI Culture System, Accelerating Bloodstream Infection Diagnostics
去年
CRISPR Therapeutics and Sirius Therapeutics Dose First Patient in Phase 2 Trial of SRSD107 for Venous Thromboembolism Prevention
去年
Sirus Therapeutics' SRSD107 Shows Promise in Phase I siRNA Trial for Thromboembolic Disorders
7个月前
Kansas City Partners Launch Integrated Theranostics Platform for Adult and Pediatric Patients
去年
Sublingual Immunotherapy Faces Hurdles in Gaining Full FDA Approval
去年
Biogen Partners with City Therapeutics in $1 Billion RNAi Collaboration for CNS Diseases
去年
City of Hope Revolutionizes Cancer Care Through Patient-Centered Approach and Expanded Access
去年
City of Hope Researchers Discover Novel Approach to Target Pancreatic Cancer's Genetic Vulnerability
去年
City of Hope to Present Groundbreaking Cancer Advances at 2025 ASCO Annual Meeting
第 1 页,共 82 页
上一页
下一页